01.06.2023 • News • PCAS • DIC • molecules

PCAS Agrees Sale of Canada Unit to DIC

PCAS has announced that it has decided to sell its Canadian subsidiary to DIC for €88.2 million.

Japanese chemicals company DIC made the offer for PCAS Canada in early May and the French complex molecules specialist has now accepted following authorization by its board of directors.

As the sale is not subject to any conditions, the transaction is expected to close in the coming days.

PCAS Canada specializes in the synthesis, development and custom manufacturing of ingredients for products used in the electronics industry, as well as producing organic molecules for pharmaceuticals.

Author: Elaine Burridge, Freelance Journalist

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.